Breast Imaging Technologies Market (Digital Mammography, 3D Breast Tomosynthesis, Breast MRI, Breast Ultrasound, Molecular Breast Imaging, Optical Imaging, PET/CT/PEM Modalities) -Technology and Market Analysis & Global Forecasts to 2017

The global breast imaging market holds a significant share of the medical device industry owing to rising awareness about the early screening of breast cancer. Though digital Mammography is the gold standard in the current breast imaging market, modalities such as breast MRI Scans, breast ultrasound and CTs are expected to drastically improve the breast Imaging Market scenario.

This research analysis provides, a detailed information on breast imaging technological advancements in breast cancer diagnosis. This research report identifies and evaluates key advancements of breast screening modalities in development and approval stages. Patent analysis, investor analysis and investment opportunity evaluation along with multi-level criteria technology benchmarking are assessed within the breast imaging sector. Strategic recommendations for technology stakeholders are elaborately discussed in this research service.

The report categorizes the entire breast imaging market into ionizing breast imaging modalities and non-ionizing breast imaging modalities based on the technical aspect of use of radiation. The technologies profiled under ionizing breast imaging modalities are Mammography, 3D Breast Tomosynthesis, Cone beam Computed Tomography (CBCT), Positron Emission Mammography (PEM), Molecular Breast Imaging (MBI) or  Breast Specific Gamma Imaging (BSGI) and Positron Emission Tomography (PET) various non-ionizing breast screening modalities covered in the report are Breast MRI, Optical Imaging, Breast thermography and Breast Ultrasound.

This report will not only cover the technical aspects of the breast imaging modalities, but also provide quantitative data analysis and growth rates for the current and emerging breast cancer screening modalities. A few technologies are coupled with other technologies, termed as dual modalities, offers better diagnostic procedures for the patients with dense breasts and high risk of cancer. The combination of spectral and Photonics phenomenon has enabled new breast imaging capabilities, providing clinicians with unique views of the structure and functioning, both at the molecular and cellular levels. The report also tracks the regional adoption and development trends, providing strategic recommendation to stay active and compete in the market space. An impact analysis of major drivers and restraints influencing the growth of the market is mapped for the period of five years.

Breast imaging market is driven majorly by rising numbers of breast cancer cases. Technological revolution to reduce the number of false positives is considered as the second major driver for breast imaging market. Safer sand comfortable imaging procedures with better efficacy and outcome also drive the breast imaging market. Emerging economies such as Asia-pacific and Middle-East and Africa are the future drivers of the breast imaging market.

Inadequate reimbursement policies are the major set-back for the breast imaging market. However, this, too, will likely improve as the technology becomes more available across the globe.

This study also analyses the competitive scenario of the world breast imaging market and the strategies employed by the key industry participants to develop products and services. The global breast Imaging market is one of the fastest growing multi-billion dollar markets in the healthcare industry with a CAGR of 15.37% reaching about $5 Billion by the year 2017. The industry is being impacted by the huge Government stimulus and continuous development in technology that leads to the introduction of innovative products.

The research analysis of breast imaging modalities is an attempt to showcase the market impact of current and emerging breast imaging technologies having excellent growth potential for the coming five years. A comprehensive analysis of the market size and global revenue has been forecasted based on the technology and by geography.

For simplified and effective research, we categorized the entire breast imaging modalities into Ionizing breast imaging  technologies and Non-ionizing breast imaging modalities based on the type of technicalities used in diverse breast screening modalities.

Each technology is thoroughly analyzed at a granular level based on geographic locations such as the Americas, Europe, Asia-Pacific, and Middle-East and Africa to provide in-depth information on market size, market share and market segmentation of global breast imaging modalities.

This report would provide an in-depth understanding of the global breast imaging market including key trends and drivers, appraisal of technological advancements, market size, forecasts, and market division by Geography.

There was only one available technology report on Breast Imaging technologies with respect to the U.S., and does not include broader aspects of the global market scenario . So this report would be the first holistic report which analyses in depth about current and emerging breast imaging modalities as well as provides global market landscape of these technologies.

Breast cancer, a form of cancer originating from the breast tissue, is the more prevalent type of cancer and is the leading cause of high mortality rates among women across the globe. Though the incidence of Breast cancer is seen in almost all geographical regions of the world, its preponderance to a greater extent in the developed economies than in the developing economies. Early diagnosis of breast cancer is believed to be important towards treatment, in order to avoid time delays, turning the cancers to malignant or metastatic. The market of breast imaging has witnessed dramatic technological evolutions since last few years. Every new technique came up with better solution to compensate the procedural gap of the last technique. At present, this market represents widely diverse technologies with newer and more comprehensive breast imaging devices.

Currently, Mammography is the gold standard technology used for the detection and diagnosis of breast cancer. However, owing to its low sensitivity and risk of exposure to radiation, new alternative modalities are gaining importance for accurate detection of breast cancers. Nuclear and Magnetic Resonance imaging have been used to detect breast cancers in high risk patients. Recently, Full Field Digital Mammography, 3D breast Tomosynthesis, Optical imaging and Molecular Breast imaging techniques are also being widely used for breast cancer screening and diagnosis. Another upcoming modality is the Whole Breast Ultrasound (WBU) which is considered as much safer, user friendly for physicians and cost effective compared to other modalities. With the growing R&D efforts in technology innovations and modality up-gradations, along with regulatory approvals, the newer breast imaging modalities offers a promising future for breast cancer diagnosis in the coming five years.

The global breast imaging market is poised to grow at a CAGR of 15.37% from 2012 reaching approximately $5 billion by 2017.

BREAST IMAGING TECHNOLOGIES MARKET - BY REVENUE, BY MODALITIES

Source: Expert Interview, Annual Reports SEC Filings & MarketsandMarkets Analysis

America is the major market for breast imaging equipments followed by Europe and they have been driving the market significantly owing to rising number of breast cancer cases across the developed economies. Other than the mature markets, emerging economies such as Asia-pacific and Middle-East are the future drivers of breast imaging market. However, one major downside to the newer modalities is their cost in comparison with conventional breast imaging. This, too, will likely to improve as the technology becomes more available and reimbursements increase.

Source: Expert Interview, Annual Reports SEC Filings & MarketsandMarkets Analysis

The key players profiled in the report are Hologic Inc., Aurora Imaging Technology, Imaging Diagnostic Systems Inc., Naviscan PET Systems Inc., GE Healthcare, Siemens Healthcare, Koning Corporation, Philips Research, U-Systems Inc., Toshiba America Medical Systems Inc., Dune Medical Technologies, Dilon Diagnostics, Planmeca GmbH, Gamma Medica Inc and AGFA Healthcare.